Relay Therapeutics Competitors and Similar CompaniesClear all

Verastem Oncology's competitors and similar companies include Walvax Biotechnology.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Walvax Biotechnology
Walvax Biotechnology
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
Founding Date
Founding Date
2010
Founding Date
2001
Type
Type
Public
Type
Public
Tags
Locations
Locations
Needham, US HQ
Walsrode, DE
Locations
Kunming, CN HQ
Employees
Employees
7328% increase
Employees
2,388
Valuation ($)
Valuation ($)
144.9 m
Valuation ($)
3.3 b

Financial

Revenue (est.)
Revenue (est.)
$30.9m (FY, 2025)
Revenue (est.)
¥2.4b (FY, 2025)
Net income
Net income
($209.5m) (FY, 2025)
Net income
¥125.2m (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 170m
Total funding raised
$ 72.8m
For sources of this data, please see the company profile

View Company Profiles

Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388

Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.

View company